Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Virus Shedding”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Testing effectiveness (Phase 2)Looking for participantsNCT05654467
What this trial is testing

Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama

Who this might be right for
Poliomyelitis
PATH 1,532
Early research (Phase 1)Study completedNCT04529538
What this trial is testing

Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines

Who this might be right for
Poliomyelitis
PATH 226
Testing effectiveness (Phase 2)Study completedNCT00767416
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety of MEDI-559 in Healthy 1 to <24 Month-Old Children

Who this might be right for
Healthy
MedImmune LLC 116
Testing effectiveness (Phase 2)Study completedNCT00344305
What this trial is testing

Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children

Who this might be right for
Healthy
MedImmune LLC 200
Testing effectiveness (Phase 2)Study completedNCT02111135
What this trial is testing

Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life

Who this might be right for
Polio
Vaxtrials S.A. 240
Early research (Phase 1)Study completedNCT00345670
What this trial is testing

Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children

Who this might be right for
Healthy
MedImmune LLC 120
Testing effectiveness (Phase 2)Study completedNCT00686075
What this trial is testing

Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants

Who this might be right for
Healthy
MedImmune LLC 1,338
Testing effectiveness (Phase 2)Study completedNCT04544787
What this trial is testing

Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates

Who this might be right for
Poliomyelitis
Pierre Van Damme 250
Early research (Phase 1)Study completedNCT04232943
What this trial is testing

Inactivated Poliovirus Vaccine (IPV) With or Without E.Coli Double Mutant Heat-Labile Toxin (dmLT) Challenge Study in Healthy Adults

Who this might be right for
Polio
PATH 87
Post-approval studies (Phase 4)Study completedNCT02992197
What this trial is testing

The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity

Who this might be right for
Rotavirus InfectionVaccine Response ImpairedVaccine Virus Shedding
University of Vermont 220
Early research (Phase 1)Study completedNCT03430349
What this trial is testing

Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults

Who this might be right for
Poliomyelitis
Pierre Van Damme 30
Testing effectiveness (Phase 2)Ended earlyNCT00508651
What this trial is testing

A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age

Who this might be right for
Healthy
MedImmune LLC 30
Testing effectiveness (Phase 2)Study completedNCT05130398
What this trial is testing

Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon

Who this might be right for
Ebola Virus Disease
Centre de Recherche Médicale de Lambaréné 120
Early research (Phase 1)Study completedNCT04227210
What this trial is testing

Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Meissa Vaccines, Inc. 20
Large-scale testing (Phase 3)Study completedNCT04811664
What this trial is testing

SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine

Who this might be right for
SARS-CoV-2 Infection
National Institute of Allergy and Infectious Diseases (NIAID) 1,923
Post-approval studies (Phase 4)Study completedNCT03735147
What this trial is testing

Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children

Who this might be right for
Influenza Vaccines
Imperial College London 12
Testing effectiveness (Phase 2)Looking for participantsNCT05644184
What this trial is testing

Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh

Who this might be right for
Poliomyelitis
PATH 2,232
Large-scale testing (Phase 3)Study completedNCT01375647
What this trial is testing

Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh

Who this might be right for
Rotavirus DiarrheaVaccine Virus SheddingTropical Enteropathy
University of Vermont 700
Early research (Phase 1)Study completedNCT00493285
What this trial is testing

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age

Who this might be right for
Respiratory Viral InfectionsRespiratory Syncytial Virus InfectionsParainfluenza Virus 3, Human
MedImmune LLC 49
Post-approval studies (Phase 4)Study completedNCT01616693
What this trial is testing

Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines

Who this might be right for
Immunity to Oral Rotavirus VaccineImmunity to Oral Polio VaccineShedding of Oral Rotavirus Vaccine
PATH 620
Load More Results